@article{460ef187a5dc404185b56ea63387188b,
title = "HIV-1-infected individuals in antiretroviral therapy react specifically with polyfunctional T-cell responses to Gag p24",
abstract = "Still no effective HIV-1 prophylactic or therapeutic vaccines are available. However, as the proportion of HIV-1-infected individuals on antiretroviral treatment is increasing, knowledge about the residual immune response is important for the possible development of an HIV-1 vaccine.",
keywords = "Antiretroviral Therapy, Highly Active, Antiviral Agents, CD4 Lymphocyte Count, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Cells, Cultured, Cytokines, Female, HIV Core Protein p24, HIV Infections, HIV Integrase, HIV-1, HLA Antigens, Humans, Male, RNA, Viral, Viral Load, nef Gene Products, Human Immunodeficiency Virus",
author = "Lea Brandt and Thomas Benfield and Gitte Kronborg and Jan Gerstoft and Anders Fomsgaard and Ingrid Karlsson",
year = "2013",
month = aug,
day = "1",
doi = "10.1097/QAI.0b013e31828fa22b",
language = "English",
volume = "63",
pages = "418--27",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams & Wilkins",
number = "4",
}